Introduction

The hosts discuss an article on the assessment of left ventricular hypertrophy in hypertrophic cardiomyopathy (HCM) and its implications for risk stratification. They highlight the challenges in estimating the risk of sudden cardiac death and the limitations of current risk evaluation methods.